1. Home
  2. OLMA vs AAMI Comparison

OLMA vs AAMI Comparison

Compare OLMA & AAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Olema Pharmaceuticals Inc.

OLMA

Olema Pharmaceuticals Inc.

HOLD

Current Price

$27.41

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

AAMI

Acadian Asset Management Inc.

HOLD

Current Price

$54.52

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLMA
AAMI
Founded
2006
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
OLMA
AAMI
Price
$27.41
$54.52
Analyst Decision
Strong Buy
Hold
Analyst Count
7
3
Target Price
$41.14
$48.67
AVG Volume (30 Days)
1.5M
198.3K
Earning Date
11-10-2025
02-05-2026
Dividend Yield
N/A
0.07%
EPS Growth
N/A
45.00
EPS
N/A
2.40
Revenue
N/A
$559,300,000.00
Revenue This Year
N/A
$17.23
Revenue Next Year
N/A
$24.02
P/E Ratio
N/A
$22.70
Revenue Growth
N/A
19.25
52 Week Low
$2.86
$22.60
52 Week High
$36.26
$55.10

Technical Indicators

Market Signals
Indicator
OLMA
AAMI
Relative Strength Index (RSI) 51.64 74.95
Support Level $26.93 $49.23
Resistance Level $29.47 $55.10
Average True Range (ATR) 1.59 1.85
MACD -0.13 0.52
Stochastic Oscillator 58.43 92.80

Price Performance

Historical Comparison
OLMA
AAMI

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About AAMI Acadian Asset Management Inc.

Acadian Asset Management Inc is a holding company that operates a systematic investment management business through its subsidiary, that offers institutional investors across the globe access to a diversified array of systematic investment strategies designed to meet a range of risk and return objectives.

Share on Social Networks: